Multidisciplinary oral, head, and neck cancer care integrates surgical oncology, microvascular reconstruction, radiation therapy, and specialized rehabilitation to eradicate disease while preserving critical functions such as speech, swallowing, and respiration. At Head & Neck Surgical Associates (HNSA) in Portland, Oregon, fellowship-trained oncologic and reconstructive surgeons collaborate through hospital networks and specialized tumor boards to design personalized treatment regimens, provide access to emerging clinical trials, and execute single-stage reconstructive procedures. This coordinated approach delivers comprehensive treatment while safeguarding long-term physiological function and quality of life.
What Is a Multidisciplinary Approach to Oral, Head, and Neck Cancer Care?
The anatomical structures of the head and neck are among the most intricate and functionally dense in the human body. Malignancies arising in the oral cavity, tongue, pharynx, larynx, salivary glands, and thyroid impact basic human capabilities: vocal communication, articulation, chewing, safe swallowing, airway maintenance, and facial expression. Consequently, the eradication of an oncologic lesion cannot occur in clinical isolation from functional preservation. A multidisciplinary approach convenes diverse medical and surgical subspecialists to evaluate each diagnosis collectively, ensuring that every facet of the disease and its subsequent recovery is addressed before interventions begin.
Historically, cancer management followed a sequential model where a surgeon excised a tumor, followed months later by referrals to radiation oncologists or reconstructive specialists. Contemporary protocols prioritize coordinated care plans combining surgery, radiation therapy, chemotherapy, targeted agents, and immunotherapy. Through formal institutional partnerships, HNSA surgeons lead collaborative efforts across specialized clinic locations throughout the Pacific Northwest. This structure ensures that patient care transitions smoothly between pre-operative diagnostic workups, surgical resection, immediate reconstruction, adjuvant oncologic therapies, and long-term surveillance.
Dual-degreed surgeons with medical (MD) and dental (DDS/DMD) credentials offer unique diagnostic and therapeutic insights for malignancies of the upper aerodigestive tract. Their specialized training bridges the gap between dental occlusion, maxillofacial skeletal biomechanics, and complex soft-tissue oncologic resection. When patients enter this system, their clinical trajectories are managed through a multidisciplinary oral, head, and neck cancer program focused on both disease-free survival and anatomical restoration.
How Do Tumor Boards Optimize Treatment Decisions?
Central to multidisciplinary cancer therapy is the multidisciplinary tumor board—a recurring clinical conference where diverse medical specialists assemble to rigorously evaluate individual patient cases. Rather than relying on a single physician’s perspective, each case undergoes systematic analysis by a panel that typically includes:
- Head and neck surgical oncologists and microvascular reconstructive surgeons
- Radiation oncologists specializing in intensity-modulated radiation therapy (IMRT) and proton therapy
- Medical oncologists with expertise in targeted systemic therapies and checkpoint inhibitor immunotherapies
- Diagnostic radiologists interpreting cross-sectional CT, MRI, and PET imaging
- Pathologists specializing in head, neck, and oral histopathology and biomarker identification
- Speech-language pathologists, dietitians, and nurse navigators
During these sessions, the team reviews radiographic studies, pathology slides, and patient medical histories to establish clinical staging and formulate evidence-based treatment plans. By balancing surgical morbidity against non-surgical alternatives like definitive chemoradiation, tumor boards prevent delays, reduce redundant testing, and align treatment protocols with national guidelines, such as those established by the National Comprehensive Cancer Network (NCCN).
Where Can Patients Access Specialized Head and Neck Cancer Care in Portland?
Specialized oncologic surgical care in the Pacific Northwest relies on established health system affiliations that grant patients access to advanced clinical facilities, inpatient resources, and intensive care units. HNSA maintains strategic clinical affiliations with two of the region’s prominent health networks: Providence Health & Services and Legacy Health.
What Services Are Provided at the Providence Oral, Head, and Neck Cancer Clinic?
The collaboration between HNSA and the Providence Cancer Center establishes an advanced destination for the diagnosis and management of benign neoplasms and aggressive malignancies involving the oral cavity, pharynx, larynx, paranasal sinuses, salivary glands, and thyroid. Operating out of specialized facilities, surgical oncologists work alongside dedicated oncology nurses, maxillofacial prosthodontists, and clinical social workers.
Dr. Ashish Patel, a fellowship-trained Head and Neck Surgical Oncologist and Reconstructive Surgeon, plays a vital role within this service. Dr. Patel coordinates with an integrated care team to execute ablative procedures paired with immediate functional reconstruction. The clinical objective extends beyond clear surgical margins to include the re-establishment of oral competence, speech intelligibility, and normal mastication. Patients treated through this program gain direct access to advanced medical technology, dedicated head and neck surgical suites, and specialized post-anesthesia recovery units geared toward complex airway management.
How Does the Legacy Good Samaritan and OHSU Knight-Legacy Collaborative Expand Options?
For more than three decades, HNSA has been a cornerstone of the Oral, Head and Neck Cancer Program at Legacy Good Samaritan Medical Center. This program has consistently achieved accreditation with commendation from the American College of Surgeons Commission on Cancer (CoC), reflecting adherence to rigorous quality standards and multidisciplinary metrics.
Dr. Allen Cheng serves as the Medical Director of this program. Holding dual doctorates in medicine and dentistry alongside advanced fellowship training in head and neck oncologic surgery and microvascular reconstruction, Dr. Cheng directs the program’s network-wide approach to complex head and neck pathology. A crucial benefit for patients in this system is the OHSU Knight-Legacy Health Cancer Collaborative. This relationship bridges community-based specialized surgical practice with an NCI-designated Comprehensive Cancer Center, granting regional patients access to nationwide multicenter clinical trials and specialized academic resources.
Patients seeking surgical evaluations can access these integrated resources through multiple portals, including specialized appointments with an oral surgeon convenient to Northwest Heights and surrounding Portland neighborhoods, facilitating prompt diagnostic biopsies and rapid hospital network onboarding.
Why Are Clinical Trials Essential for Advanced Head and Neck Malignancies?
Standard oncologic regimens have improved survival rates, yet advanced-stage carcinomas and recurrent or metastatic diseases require innovative therapeutic interventions. Clinical trials evaluate novel pharmacological agents, surgical devices, and treatment sequences before they become standard practices globally.
Through HNSA’s hospital collaborations and active involvement with the Head and Neck Institute, patients have direct pathways to clinical studies that would otherwise be unavailable in private surgical settings. Patients gain the multidisciplinary advantage in Portland for advanced treatments and clinical trials, expanding their options when facing aggressive or treatment-resistant malignancies.
How Do Immunotherapy and Targeted Agents Change Patient Outcomes?
One of the most consequential advancements in head and neck surgical oncology is the incorporation of immunotherapy, particularly immune checkpoint inhibitors targeting the PD-1/PD-L1 pathway. Squamous cell carcinoma of the head and neck (HNSCC) often evades immune surveillance by exploiting these regulatory checkpoints. Monoclonal antibodies counteract this mechanism, restoring T-cell capacity to recognize and destroy malignant cells.
Investigative protocols administered through Providence and the OHSU Knight-Legacy Collaborative explore neoadjuvant immunotherapy—delivering systemic immune modulators prior to surgical resection. This sequence aims to shrink primary tumors, neutralize microscopic lymph node metastasis, and generate long-term immunologic memory to prevent disease recurrence. Clinical research also evaluates targeted small-molecule inhibitors, individualized therapeutic cancer vaccines, and treatment de-escalation strategies for human papillomavirus (HPV)-associated oropharyngeal cancers to reduce radiation toxicities while maintaining exceptional cure rates.
How Does Microvascular Reconstruction Restore Form and Function After Tumor Resection?
The ablative phase of head and neck cancer surgery focuses on achieving complete tumor resection with negative histologic margins. However, removing tumors from the mandible, maxilla, tongue, or pharyngeal walls can leave substantial anatomical defects. Leaving these defects unreconstructed or using basic regional tissue flaps often leads to permanent functional impairments, including swallowing disorders, speech loss, salivary drooling, and noticeable facial deformities.
Microvascular reconstructive surgery represents the standard of care for extensive defects. Surgeons transfer vascularized bone, muscle, and soft tissue—known as free tissue transfer or free flaps—from distant donor sites to the head and neck. Under an operating microscope, surgeons suture microvascular arteries and veins measuring 1 to 3 millimeters in diameter to recipient blood vessels in the neck, establishing immediate blood supply to the transplanted tissue. Common donor sites include:
- Fibula Free Flap: Supplies dense cortical bone to reconstruct segmental mandibular or maxillary defects, supporting future endosseous dental implants.
- Radial Forearm Free Flap: Provides thin, pliable cutaneous tissue ideal for reconstructing the mobile tongue, floor of the mouth, soft palate, and pharynx.
- Anterolateral Thigh (ALT) Flap: Offers adaptable volume and cutaneous surface area to reconstruct extensive soft-tissue defects of the tongue, cheek, or neck base.
- Scapular Flap: Delivers variable combinations of vascularized bone and soft tissue for complex midface and palatal composite defects.
Surgeons Dr. Allen Cheng, Dr. Ashish Patel, and Dr. Baber Khatib specialize in microvascular reconstructive techniques within their partnered surgical clinics, executing both tumor excision and complex reconstruction in a single operative session to accelerate systemic therapy readiness.
What Is the ‘Jaw in a Day’ Surgical Technique?
Historically, patients requiring composite jaw resections faced a prolonged multi-step recovery process spanning twelve to twenty-four months. The initial surgery removed the diseased bone and placed a temporary reconstruction plate or non-vascularized bone graft. After months of tissue healing and adjuvant radiation therapy, secondary operations were required to install dental implants, followed by months of prosthetic integration before final dental bridges could be loaded.
Under the leadership of reconstructive surgeons like Dr. Baber Khatib, advanced digital protocols make single-stage reconstructive procedures—commonly termed “Jaw in a Day”—a reality. In this procedure, surgeons perform:
- Precise resection of the mandibular or maxillary tumor using computer-milled cutting guides.
- Simultaneous harvest and osteotomy of a vascularized fibular free flap to match the contour of the resected jaw.
- Microvascular vessel anastomosis to ensure immediate flap perfusion.
- Immediate placement of endosseous dental implants into the transplanted fibula bone.
- Fixation of a pre-fabricated dental prosthesis directly to the implants before the patient emerges from general anesthesia.
This coordinated intervention eliminates secondary bone-grafting surgeries, maintains facial vertical dimension, prevents soft-tissue contraction, and allows patients to wake up with functional, aesthetic dentition. This single-stage approach minimizes psychological trauma and enables patients to resume oral nutritional intake more quickly.
Why Is Virtual Surgical Planning Critical for Facial Symmetry?
Virtual Surgical Planning (VSP) has transformed reconstructive head and neck oncology from an interpretive discipline into a precise, computer-guided science. Prior to entering the operating room, high-resolution multi-slice CT scans of the patient’s head, neck, and donor sites are uploaded into three-dimensional modeling software.
During a virtual pre-operative session, the surgical team performs a simulated tumor resection on digital anatomical models, establishing safe margins. The computer calculates the exact osteotomy angles needed to harvest and contour donor bone to match the native facial skeleton down to fractions of a millimeter. Patient-specific titanium fixation plates, cutting guides, and provisional dental prostheses are then custom-fabricated using 3D printing technology.
The intraoperative use of VSP cutting jigs and pre-bent plates shortens operative ischemia times (the duration tissue is separated from its blood supply), ensures symmetric mandibular contours, and aligns dental arches accurately. This precision reduces post-operative complications, accelerates hospital discharge, and supports long-term oral rehabilitation.
What Does Holistic Rehabilitation and Long-Term Survivorship Involve?
Successful cancer management extends beyond clear margins and healed surgical wounds. The long-term wellness of a head and neck cancer patient requires ongoing rehabilitation that addresses physiological, nutritional, and psychological recovery.
Comprehensive cancer survivorship incorporates structured post-operative monitoring to identify early recurrences, manage radiation-induced tissue fibrosis, and treat salivary gland dysfunction. Consistent communication between surgical specialists, primary care providers, and outpatient therapists ensures patients navigate recovery with tailored clinical guidance.
How Do Speech Pathologists and Nutritionists Assist Recovery?
Speech-language pathologists (SLPs) and registered dietitians are integrated into patient care before surgery begins. Baseline assessments establish functional scores for speech intelligibility, phonation, and swallowing mechanics. These pre-treatment evaluations allow clinicians to anticipate functional deficits and prepare patients with preventative exercises.
Following surgical resection and microvascular reconstruction, early swallowing rehabilitation helps prevent disuse atrophy of the pharyngeal musculature. Clinicians perform modified barium swallow studies (MBSS) and fiberoptic endoscopic evaluations of swallowing (FEES) to analyze pharyngeal transit times and prevent aspiration. SLPs implement targeted tongue strengthening and compensatory swallowing maneuvers (such as the Mendelsohn maneuver and supraglottic swallow) to help patients safely resume an oral diet.
Concurrently, clinical dietitians assess caloric, fluid, and macronutrient requirements. Patients undergoing head and neck cancer therapy often experience hypermetabolic demands due to surgical healing, localized tissue inflammation, and the side effects of chemoradiation, such as mucositis and altered taste. Dietitians design tailored nutrition regimens—delivered through oral supplements or temporary enteral feeding tubes—to prevent muscle wasting, support wound healing, and maintain the strength needed to complete post-operative radiation and systemic therapies.
Frequently Asked Questions
What are the early symptoms of oral, head, and neck cancer?
Early signs of head and neck cancer include persistent oral ulcers or sores that do not heal within two weeks, unilateral throat soreness, unexplained hoarseness or voice changes, painless neck masses, difficulty or pain when swallowing, unexplained dental loosening, and numbness along the jaw, tongue, or face. Any persistent, unexplained symptom lasting longer than two weeks warrants a specialized clinical evaluation.
Why is a dual-degreed surgeon beneficial for oral cancer treatment?
Surgeons holding dual degrees in medicine (MD) and dentistry (DDS or DMD) possess deep understanding of the structural anatomy, occlusion, and function of the oral cavity and facial skeleton. This dual background is particularly valuable in head and neck cancer care, where tumor resection directly impacts the alignment of teeth, jaw mechanics, airway patency, and facial aesthetics. Dual-trained surgeons coordinate ablative cancer excision with advanced reconstructive techniques, including dental implant placement and microvascular bone transfer, within a unified surgical treatment plan.
What is the difference between ablative surgery and reconstructive surgery?
Ablative surgery focuses on the complete surgical removal of a tumor, along with a margin of healthy tissue and involved cervical lymph nodes, to eradicate the cancer. Reconstructive surgery is the subsequent or concurrent procedure that repairs the resulting tissue defect. Reconstructive techniques utilize skin grafts, local tissue flaps, or microvascular free tissue transfers (such as bone from the fibula or soft tissue from the forearm) to re-establish the structural integrity, appearance, and critical functions of the head and neck.
How does microvascular free flap surgery work?
Microvascular free flap surgery involves harvesting tissue—which may include skin, muscle, bone, or a combination—from a donor site on the patient’s body (such as the leg, forearm, thigh, or back) along with its feeding artery and draining vein. This tissue is transplanted to the surgical defect in the head and neck. Under an operating microscope, the surgeon connects the tiny blood vessels of the flap to recipient vessels in the neck using microscopic sutures, restoring direct blood flow to ensure the transplanted tissue survives and heals properly.
Can patients receive radiation therapy after reconstructive surgery?
Yes. Adjuvant radiation therapy, often combined with systemic chemotherapy, is frequently recommended for advanced-stage or high-risk head and neck cancers following surgical resection. Modern microvascular free flaps tolerate therapeutic radiation doses well once surgical incisions have healed, typically four to six weeks post-operatively. Coordinated virtual surgical planning ensures that reconstructive hardware and dental implants are positioned to facilitate safe and accurate delivery of radiation beams to target tissues.
